Resveratrol as an Anti-inflammatory Agent in Coronary Artery Disease: A Systematic Review, Meta-Analysis and Meta-Regression

被引:3
作者
Damay, Vito A. [1 ]
Ivan, Ignatius [2 ]
机构
[1] Univ Pelita Harapan, Dept Cardiovasc Med, Tangerang 15811, Banten, Indonesia
[2] Jakarta Var Clin, Jakarta 12210, Indonesia
关键词
anti-inflammation; coronary artery disease; nitric oxide; resveratrol; systematic review; BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; CLINICAL-TRIAL; PUBLICATION BIAS; SUPPLEMENTATION; INFLAMMATION; CARDIOPROTECTION; ATHEROSCLEROSIS; SENSITIVITY; METABOLISM;
D O I
10.1007/s11655-024-3665-0
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
BackgroundResveratrol is a non-flavonoid polyphenol that shows promise in reducing pro-inflammatory factors and maintaining endothelial function, which hints at its potential role in slowing atherosclerosis and preventing acute coronary events.ObjectiveTo study the cardioprotective effects of resveratrol on inflammatory mediators and endothelial function in patients with coronary artery disease (CAD).MethodsA thorough search was conducted in databases (Cochrane Library, ProQuest, PubMed, LILACS, ScienceDirect, Springer, Taylor&Francis, CNKI, Wanfang, and Weipu) until September 24, 2023. The vasopro-inflammatory mediators, endothelial function and outcomes related to cardiovascular events were observed. Titles and abstracts were assessed, and bias was evaluated with Cochrane RoB 2.0. Heterogeneity of results was explored by meta-regression, certainty of evidence was assessed by the GRADE system, and conclusive evidence was enhanced by trial sequence analysis.ResultsTen randomized controlled trials and 3 animal studies investigated resveratrol's impact on inflammatory mediators and endothelial function. In primary prevention studies, meta-analysis showed a significant reduction (95% CI: -0.73 to -0.20; P=0.0005) in tumor necrosis factor-alpha (TNF-alpha) expression with resveratrol, demonstrating a dose-dependent relationship. No significant difference was observed in interleukin-6 (IL-6) expression with P=0.58 for primary prevention and P=0.57 for secondary prevention. Vascular endothelial nitric oxide synthase (eNOS) expression was significantly increased after resveratrol pre-treatment following CAD events. Secondary prevention studies yielded no significant results; however, meta-regression identified associations between age, hypertension, and lower doses with the extent of TNF-alpha alterations. High certainty of evidence supported TNF-alpha reduction, while evidence for IL-6 reduction and eNOS elevation was deemed low.ConclusionResveratrol reduces TNF-alpha in individuals at risk for CAD, specifically 15 mg per day. However, its usefulness in patients with confirmed CAD is limited due to factors such as age, high blood pressure, and insufficient dosage. Due to the small sample size, the reduction of IL-6 is inconclusive. Animal studies suggest that resveratrol enhances endothelial function by increasing eNOS. (PROSPERO registration No. CRD42023465234)
引用
收藏
页码:927 / 937
页数:11
相关论文
共 50 条
[41]   Systematic review and meta-analysis of association of polymorphisms in inflammatory cytokine genes with coronary artery disease [J].
Samira Tabaei ;
Morteza Motallebnezhad ;
Seyedeh Samaneh Tabaee .
Inflammation Research, 2020, 69 :1001-1013
[42]   Efficacy of transdermal anti-inflammatory patches for musculoskeletal pain: a systematic review and meta-analysis [J].
Sanchez, Maria B. ;
Callaghan, Michael J. ;
Selfe, James ;
Twigg, Michael ;
Smith, Toby .
PAIN MANAGEMENT, 2024, 14 (10-11) :557-569
[43]   Comparative Effectiveness of Anti-Inflammatory Drug Treatments in Coronary Heart Disease Patients: A Systematic Review and Network Meta-Analysis [J].
Wudexi, Ivan ;
Shokri, Elica ;
Abo-Aly, Mohamed ;
Shindo, Kazuhiro ;
Abdel-Latif, Ahmed .
MEDIATORS OF INFLAMMATION, 2021, 2021
[44]   Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis of observational studies [J].
Ungprasert, Patompong ;
Suksaranjit, Promporn ;
Spanuchart, Ittikorn ;
Leeaphorn, Napat ;
Permpalung, Nitipong .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2014, 44 (01) :63-67
[45]   Anti-inflammatory effects of oral supplementation with curcumin: a systematic review and meta-analysis of randomized controlled trials [J].
Ferguson, Jessica J. A. ;
Abbott, Kylie A. ;
Garg, Manohar L. .
NUTRITION REVIEWS, 2021, 79 (09) :1043-1066
[46]   Zinc status and coronary artery disease: A systematic review and meta-analysis [J].
Banik, Sujan ;
Ghosh, Antara .
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2022, 73
[47]   Angioplasty and stents in coronary artery disease:: a systematic review and meta-analysis [J].
Dündar, Y ;
Hill, RA ;
Bakhai, A ;
Dickson, R ;
Walley, T .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2004, 38 (04) :200-210
[48]   The influence of training characteristics on the effect of exercise training in patients with coronary artery disease: Systematic review and meta-regression analysis [J].
Kraal, Jos J. ;
Vromen, Tom ;
Spee, Ruud ;
Kemps, Hareld M. C. ;
Peek, Niels .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 245 :52-58
[49]   A systematic review, meta-analysis, and meta-regression of patient education for secondary prevention in patients with coronary heart disease: impact on psychological outcomes [J].
Shi, Wendan ;
Ghisi, Gabriela L. M. ;
Zhang, Ling ;
Hyun, Karice ;
Pakosh, Maureen ;
Gallagher, Robyn .
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2022, 21 (07) :643-654
[50]   The association between age at menarche and depression: A systematic review and meta-analysis with meta-regression [J].
Ghadirzadeh, Erfan ;
Moosazadeh, Mahmood ;
Shakeriastani, Kiarash ;
Zarrinkamar, Maryam ;
Gheibi, Mobina ;
Elyasi, Forouzan ;
Geran, Mojgan .
CLINICS, 2025, 80